The pathways identified linked to steroid metabolism, and to metabolites associated with BMI, lipoprotein cholesterols and kidney function, namely STYXL1-POR, SLC2A1-TXNIP, and PFKFB2, may reveal the association of T2D risk factors or complications with methylation mechanisms. Here, PFKFB2 is linked to type 2 diabetes mellitus.